CAPTRUST Financial Advisors’s VanEck Biotech ETF BBH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-79	Closed	-$12K	–	2250
2022 Q2	$12K	Hold	79	–	–	﹤0.01%	3641
2022 Q1	$13K	Hold	79	–	–	﹤0.01%	3643
2021 Q4	$15K	Hold	79	–	–	﹤0.01%	3467
2021 Q3	$16K	Hold	79	–	–	﹤0.01%	3298
2021 Q2	$16K	Hold	79	–	–	﹤0.01%	3258
2021 Q1	$14K	Hold	79	–	–	﹤0.01%	3224
2020 Q4	$13K	Hold	79	–	–	﹤0.01%	2453
2020 Q3	$13K	Hold	79	–	–	﹤0.01%	2169
2020 Q2	$13K	Buy	+79	New	+$12K	﹤0.01%	2088
2019 Q4	–	Sell	-79	Closed	-$9K	–	1077
2019 Q3	$9K	Hold	79	–	–	﹤0.01%	1520
2019 Q2	$10K	Hold	79	–	–	﹤0.01%	1494
2019 Q1	$10K	Sell	79 -16	-17%	-$2.02K	﹤0.01%	1377
2018 Q4	$11K	Buy	95 +79	+494%	+$9.54K	﹤0.01%	1193
2018 Q3	$2K	Buy	+16	New	+$2.08K	﹤0.01%	1463

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PGFC

Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CAPTRUST Financial Advisors's BBH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of VanEck Biotech ETF (BBH) in Q3 2022, closing a stake of 79 shares — an estimated $12K sold.

CAPTRUST Financial Advisors first reported a position in BBH in Q3 2018 and held it in 14 quarters. The position peaked at $16K in Q3 2021. 102 funds tracked by Wall St. Rank hold BBH as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining VanEck Biotech ETF position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 79 VanEck Biotech ETF shares in Q3 2022, an estimated $12K.
CAPTRUST Financial Advisors first reported a position in VanEck Biotech ETF in Q3 2018 and held it in 14 quarters.
CAPTRUST Financial Advisors's VanEck Biotech ETF position peaked at $16K in Q3 2021.
102 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.